Evidence map›Paper›PMID 41139940›Full record

ArticleBritish journal of haematology2026

New cases expand the genotype, phenotype and therapeutic landscape of H syndrome.

Clément Triaille, Julie Beauchemin, Philippe M Campeau, Hugo Chapdelaine, Julie Dery, Maria Kondyli, Grant Mitchell, Julie Powell, Sophie Turpin, Guilhem Cros and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in British journal of haematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Clément TriaillePediatric Rheumatology and Immunology, Department of Pediatrics, CHU Sainte-Justine, Université de Montréal, Montreal, Quebec, Canada.ORCID https://orcid.org/0000-0001-9227-3820
Julie BeaucheminDepartment of Rheumatology, Hopital Charles Lemoyne, Longueuil, Quebec, Canada.
Philippe M CampeauDivision of Medical Genetics, Department of Pediatrics, CHU Sainte-Justine, Montreal, Quebec, Canada.
Hugo ChapdelaineDepartment of Immunology and Allergology, Centre Hospitalier de l'Université de Montréal, Université de Montréal, Montreal, Quebec, Canada.
Julie DeryDepartment of Radiology, CHU Sainte-Justine, Université de Montréal, Montreal, Quebec, Canada.
Maria KondyliDepartment of Hematology and Oncology, Department of Pediatrics, CHU Sainte-Justine, Université de Montréal, Montreal, Quebec, Canada.
Grant MitchellDivision of Medical Genetics, Department of Pediatrics, CHU Sainte-Justine, Montreal, Quebec, Canada.
Julie PowellDermatology, Department of Pediatrics, CHU Sainte-Justine, Université de Montréal, Montreal, Quebec, Canada.
Sophie TurpinNuclear Medicine - Medical Imaging, CHU Sainte-Justine, University of Montreal, Montreal, Quebec, Canada.
Guilhem CrosDepartment of Immunology and Allergology, Centre Hospitalier de l'Université de Montréal, Université de Montréal, Montreal, Quebec, Canada.
Fabien TouzotPediatric Rheumatology and Immunology, Department of Pediatrics, CHU Sainte-Justine, Université de Montréal, Montreal, Quebec, Canada.ORCID https://orcid.org/0000-0002-0889-4905

Funding

CHU Sainte-Justine FoundationWallonie-Bruxelles International
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

histiocytosisHLHH syndromeJAK inhibitorMEK inhibitorretroperitoneal fibrosisSCL29A3tocilizumab

Identifiers

PMID41139940
PMCPMC12819107

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.